These findings suggested that the protective effects of CEL or COT extract against NAFLD may be mediated through their modulation of FGF21/AMPK/PGC-1α signaling pathway. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.